Table 2.
Baseline characteristics of participants of HI-Light trial
| Baseline characteristics | All groups | Active group | Placebo group |
|---|---|---|---|
| Number of participants |
29 |
19 |
10 |
| Age range (years) |
5–71 |
5–71 |
13–51 |
| Adult/child |
23/6 |
14/5 |
9/1 |
| Age mean (years); SD |
31.7 ± 17.9 |
27.63 ± 18.6 |
39.4 ± 13.5 |
| Adults |
38.6 ± 14.8 |
38 ± 15.8 |
42.3 ± 10.85 |
| Children |
10.25 ± 3.5 |
9.9 ± 3.6 |
13 ± n/a |
| Sex (female/male) |
15/14 |
10/9 |
5/5 |
| Ethnicity: |
|
|
|
| White British |
20/29 (69%) |
12/19 (64%) |
8/10 (80%) |
| Mixed |
1/29 (3.5%) |
1/19 (5%) |
None |
| Black/Black Caribbean |
2/29 (7%) |
2/19 (11%) |
None |
| Indian |
2/29 (7%) |
1/19 (5%) |
1/10 (10%) |
| Pakistani |
1/29 (3.5%) |
1/19 (5%) |
None |
| Asian |
2/29 (7%) |
1/19 (5%) |
1/10 (10%) |
| Other ethnic group |
1/29 (3.5%) |
1/19 (5%) |
None |
| Duration of vitiligo (years) |
|
|
|
| Mean ± SD (min; max) |
12.28 ± 9.67 (min = 2; max = 33) |
11.36 ± 10.12 (min = 2; max = 33) |
14.01 ± 8.5 (min = 5; max = 28) |
| Vitiligo activity per participant (overall) |
|
|
|
| Stable |
6 |
3 |
3 |
| Spreading |
19 |
14 |
5 |
| Repigmenting |
4 |
2 |
2 |
| BSA% covered by vitiligo Mean ± SD (min; max) |
8.83 ± 6.19 (min = 2; max = 25) |
9.84 ± 5.96 (min = 3; max = 25) |
6.9 ± 6.17 (min = 2; max = 21) |
| Number of lesions | 84 | 56 | 28 |